Blueprint for Change

Treating the Indonesian Diabetes Pandemic: A Case Study from Novo Nordisk

Danish pharmaceutical company Novo Nordisk has released a new case study that examines the challenges for diabetes care in Indonesia. The study reflects the company's work to provide diabetes care across Indonesia, a country where millions of people have diabetes but less than one per cent receives proper treatment.

Novo Nordisk Launches ‘Blueprint for Change’ Case on Bangladesh

Novo Nordisk made available the fourth case of its Blueprint for Change series, which focuses on Bangladesh.

Subscribe to Blueprint for Change